E/M Coding Alert - 2010 Issue 36
Laboratory Coding: 83718 Reporting: Maximize Lipid Screening Pay
Subscribe or sign in to view the full article.
Article Overview
This article reviews laboratory billing and coding guidance for lipid screening under Medicare and related payer rules. It focuses on the general coverage context for screening tests, documentation requirements for ordered testing, CLIA-waived reporting, and the diagnosis coding issues that arise when screening is performed for asymptomatic patients. The content is aimed at laboratory coders, billing staff, and providers who need to understand how lipid screening claims are supported and reported.
Why This Topic Matters
Lipid screening can generate frequent claims, and small documentation or coding errors can affect payment. Understanding the article helps labs and billing teams recognize when screening applies, what supporting records are expected, and how diagnosis selection affects claim support.
What You Will Learn
- How lipid screening is described in a Medicare coverage context
- What documentation should support ordered laboratory testing
- How CLIA-waived lab reporting is addressed
- How screening-related diagnosis coding is discussed for asymptomatic patients
- How the article frames the difference between screening and diagnostic testing
Who Should Read This
- Laboratory coders
- Medical billers
- Revenue cycle staff
- Pathology and lab managers
- Primary care providers
- Compliance staff
Codes Discussed
Modifiers Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com